June 05, 2026 — RNews

#obesity — Friday, June 05, 2026 (1 items)

hot top new

← prev day next day →

0

Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial. (nature.com)

Rosenstock J … Coll B Nature Medicine 2026-06-05

#metabolism #clinical trial #pharmacotherapy #obesity